Patrick Brannelly

Patrick Brannelly is the founding CEO of the 10,000 Brains Project, a philanthropic initiative that supports the ethical and inclusive use of AI in the development of better treatments for Alzheimer's disease and other neurodegenerative disorders.

Pat has nearly 20 years of experience building groundbreaking neuroscience initiatives. Most recently, he was a member of the Health & Life Sciences team at Gates Ventures, where he served as the Director of Partnerships & Business Development for the non-profit Alzheimer’s Disease Data Initiative. Prior to this, he was the Managing Director of the Rainwater Charitable Foundation’s Tau Consortium, which seeks to accelerate the development of new treatments for Alzheimer’s disease and frontotemporal dementia.

Earlier in his career, Pat was the founding CEO of NeoCORTA and the Director of Partnerships & Group Programs at Posit Science, both early-stage brain health technology ventures. He has also served in the US and Europe as a management consultant in the pharmaceutical, energy, and technology sectors. A frequent member of boards and steering committees, he currently serves as a Board member of Stroke Onward and is an advisor to several early-stage neuroscience ventures.

Pat holds a BA in Psychology from Harvard College, an MBA with Distinction from Harvard Business School, and an MSc in Applied Neuroscience with Distinction from King’s College London. He is a former Assistant Professor of entrepreneurship and strategy at California State University, Fresno.